← FDA DRUG APPROVALS

FDA ANDA · ANDA074540

NICARDIPINE HYDROCHLORIDE

Sponsor: ANI PHARMS

APPLICATION
ANDA074540
TYPE
ANDA
ORIGINAL APPROVAL
1996-10-28
LATEST ACTION
2001-11-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

NICARDIPINE HYDROCHLORIDEDiscontinued
NICARDIPINE HYDROCHLORIDE 20MG · CAPSULE · ORAL
NICARDIPINE HYDROCHLORIDEDiscontinued
NICARDIPINE HYDROCHLORIDE 30MG · CAPSULE · ORAL

Approval history

2001-11-05Labeling · Supplement 11AP
2001-08-30Manufacturing (CMC) · Supplement 10AP
2000-07-07Manufacturing (CMC) · Supplement 8AP
2000-02-25Labeling · Supplement 9AP
1999-10-29Manufacturing (CMC) · Supplement 6AP
1999-10-29Manufacturing (CMC) · Supplement 7AP
1998-03-09Manufacturing (CMC) · Supplement 4AP
1997-07-11Manufacturing (CMC) · Supplement 2AP
1997-07-11Manufacturing (CMC) · Supplement 3AP
1997-07-11Manufacturing (CMC) · Supplement 1AP
1996-10-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →